RT Journal Article
SR Electronic
T1 Conceptual framework of episodic disability in the context of Long COVID: Findings from a community-engaged international qualitative study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.28.24308048
DO 10.1101/2024.05.28.24308048
A1 O’Brien, Kelly K.
A1 Brown, Darren A.
A1 McDuff, Kiera
A1 St. Clair-Sullivan, Natalie
A1 Carusone, Soo Chan
A1 Thomson, Catherine
A1 McCorkell, Lisa
A1 Wei, Hannah
A1 Goulding, Susie
A1 O’Hara, Margaret
A1 Roche, Niamh
A1 Stokes, Ruth
A1 Kelly, Mary
A1 Cheung, Angela M.
A1 Erlandson, Kristine M.
A1 Harding, Richard
A1 Vera, Jaime H.
A1 Bergin, Colm
A1 Robinson, Larry
A1 Avery, Lisa
A1 Bannan, Ciaran
A1 Torres, Brittany
A1 O’Donovan, Imelda
A1 Malli, Nisa
A1 Solomon, Patricia
YR 2024
UL http://medrxiv.org/content/early/2024/05/30/2024.05.28.24308048.1.abstract
AB Background Increasing numbers of adults are living with the health-related consequences of Long COVID. The Episodic Disability Framework (EDF), derived from perspectives of adults living with HIV, characterizes the multidimensional and episodic nature of health-related challenges (disability) experienced by an individual. Our aim was to determine the applicability of the Episodic Disability Framework to conceptualize the health-related challenges experienced among adults living with Long COVID.Methods We conducted a community-engaged qualitative descriptive study involving online semi-structured interviews. We recruited adults who self-identified as living with Long COVID via collaborator community organizations in Canada, Ireland, United Kingdom, and United States. We purposively recruited for diversity in age, gender identity, ethnicity, sexual orientation, and time since initial COVID-19 infection. We used a semi-structured interview guide informed by the EDF to explore experiences of disability living with Long COVID, specifically health-related challenges and how challenges were experienced over time. We conducted a group-based content analysis.Results Of the 40 participants, the median age was 39 years; and the majority were white 73%), women (63%), living with Long COVID for ≥1 year (83%). Consistent with the Episodic Disability Framework, disability was described as multidimensional and episodic, characterized by unpredictable periods of health and illness. Experiences of disability were consistent with the three main components of the Framework: A) dimensions of disability (physical, cognitive, mental-emotional health challenges, difficulties with day-to-day activities, challenges to social inclusion, uncertainty); B) contextual factors, extrinsic (social support; accessibility of environment and health services; stigma and epistemic injustice) and intrinsic (living strategies; personal attributes) that exacerbate or alleviate dimensions of disability; and C) triggers that initiate episodes of disability.Conclusions The Episodic Disability Framework provides a way to conceptualize disability the multidimensional and episodic nature of disability experienced by adults living with Long COVID. The Framework provides guidance for future measurement of disability, and health and rehabilitation approaches to enhance practice, research, and policy in Long COVID.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://bmjopen.bmj.com/content/12/3/e060826 Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Toronto Health Sciences Research Ethics Board (Protocol #41749).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.